106 related articles for article (PubMed ID: 22399626)
21. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
22. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.
Aldaz CM; Chen T; Sahin A; Cunningham J; Bondy M
Cancer Res; 1995 Sep; 55(18):3976-81. PubMed ID: 7664266
[TBL] [Abstract][Full Text] [Related]
23. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients.
Jeong S; Park S; Park BW; Park Y; Kwon OJ; Kim HS
PLoS One; 2014; 9(5):e98284. PubMed ID: 24870375
[TBL] [Abstract][Full Text] [Related]
25. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
Weng PJ; Fu YM; Ding SX; Xu DP; Lin A; Yan WH
Hum Immunol; 2011 May; 72(5):406-11. PubMed ID: 21377504
[TBL] [Abstract][Full Text] [Related]
26. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
[TBL] [Abstract][Full Text] [Related]
27. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
[TBL] [Abstract][Full Text] [Related]
28. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
30. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
31. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
Gervais A; Levêque J; Bouet-Toussaint F; Burtin F; Lesimple T; Sulpice L; Patard JJ; Genetet N; Catros-Quemener V
Breast Cancer Res; 2005; 7(3):R326-35. PubMed ID: 15987427
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
34. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
35. Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Garcia-Etienne CA; Barile M; Gentilini OD; Botteri E; Rotmensz N; Sagona A; Farante G; Galimberti V; Luini A; Veronesi P; Bonanni B
Ann Surg Oncol; 2009 Dec; 16(12):3380-7. PubMed ID: 19649554
[TBL] [Abstract][Full Text] [Related]
36. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
37. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
38. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
39. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.
Synowiec E; Stefanska J; Morawiec Z; Blasiak J; Wozniak K
Mutat Res; 2008 Dec; 648(1-2):65-72. PubMed ID: 18977234
[TBL] [Abstract][Full Text] [Related]
40. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
Heikkinen T; Kärkkäinen H; Aaltonen K; Milne RL; Heikkilä P; Aittomäki K; Blomqvist C; Nevanlinna H
Clin Cancer Res; 2009 May; 15(9):3214-22. PubMed ID: 19383810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
